Schizophrenia Research
Volume 89, Issue 1 , Pages 91-100 , January 2007

Does antipsychotic polypharmacy increase the risk for metabolic syndrome?

Received 11 July 2006 ,Revised 13 August 2006 ,Accepted 16 August 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Grant support: The Zucker Hillside Hospital Mental Advanced Center for Intervention and Services Research for the Study of Schizophrenia (MH074543-01) from the National Institute of Mental Health, Bethesda, Md.

PII: S0920-9964(06)00364-1

doi: 10.1016/j.schres.2006.08.017

Schizophrenia Research
Volume 89, Issue 1 , Pages 91-100 , January 2007

Article Tools

* Image Usage & Resolution